FDA Warns Against Laparoscopic Power MorcellationJuly 15, 2015

The Food and Drug Administration (FDA) has issued a warning against the use of laparoscopic power morcellation for hysterectomy or myomectomy (uterine fibroid removal). There are concerning reports of the spread of unsuspected cancerous tissue—specifically, uterine sarcoma—during laparoscopic hysterectomy. Laparoscopic power morcellation lawsuits have now been filed by women alleging they were harmed by the use of …

Power Morcellators and the Risk of Ovarian CancerFebruary 20, 2015

Recent studies in the Journal of Obstetrics and Gynecology, as well as the Journal of the American Medical Association, Oncology, have found that women undergoing hysterectomies with the use of a power morcellator have the potential risk of having an unknown and undiagnosed cancer exacerbated.  The power morcellator can be used with the “DaVinci” surgical …

New studies consider the risk of power morcellators

New research is adding to scrutiny of a surgical tool called the laparoscopic power morcellator that the FDA has warned against using in a vast majority of cases because of its potential to spread hidden cancer in common gynecological procedures. Researchers at the University of Michigan’s health department had found that of women who had hysterectomies …